MVP — Medical Developments International Share News
0.000.00%
- AU$41.12m
- AU$21.42m
- AU$42.57m
Brief: Medical Developments International Says Expect Improved FY24 Underlying EBIT
Brief: Medical Developments Intl Says Believe Europe Can Deliver Solid Growth Over Longer Term
Brief: Medical Developments International Says FY Net Loss Attributable A$5.6 Mln
Brief: Medical Developments International Posts HY NPAT Of A$2.7 Mln
Brief: Medical Developments International Says It Discontinued Preparation Of China Clinical Trials For Penthrox
Australia's Medical Developments rises after ending China trials for pain drug
Brief: Medical Developments International Seeks Trading Halt
Brief: Medical Developments International Announces A$30M Capital Raise
Brief: Medical Developments International Signs New Penthrox Licensing Agreement In Canada
Brief: Medical Developments International Says Mark Edwards Resigned As CFO
Factbox: Latest on the worldwide spread of the coronavirus
Australia Stock Exchange release from MEDICAL DEVELOPM : PRE_NR Ends: 08:48:17
Australia Stock Exchange release from MEDICAL DEVELOPM : US FDA Investor Presentation
Brief: Medical Developments International Says U.S. FDA Lifted Agency's Clinical Hold On Penthrox
Australia Medical Developments chases best day in almost 12 years on FDA nod for trial
Australia Stock Exchange release from MEDICAL DEVELOPM : Green Whistle gets the Green Light - FDA Clears US Trial
Australia Stock Exchange release from MEDICAL DEVELOPM : PRE_NR Ends: 10:39:10
Brief: Medical Developments International Seeks Trading Halt
Australia Stock Exchange release from MEDICAL DEVELOPM : Trading Halt